Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Santa,Clara,,Ca,,Usa,-,Nov,22,,2023:,Intel,Corporation's

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.

Shares of Intel Corporation (NASDAQ:INTC) fell in pre-market trading following second-quarter results.

Intel reported a loss for the second quarter, while sales topped estimates. Intel expects third-quarter revenue to be in the range of $12.6 billion to $13.6 billion, versus estimates of $12.63 billion. The company anticipates a third-quarter loss of 24 cents per share versus estimates for a loss of 18 cents per share. Intel CEO Lip-Bu Tan shared a memo with employees saying that the company will reduce its workforce to 75,000 employees by the end of the year through layoffs and attrition.

Intel shares dipped 5.9% to $21.30 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Absci Corporation (NASDAQ:ABSI) declined 13.7% to $3.03 in pre-market trading after the company announced the pricing of public offering of common stock.
  • AST SpaceMobile, Inc. (NASDAQ:ASTS) fell 9.2% to $54.56 in pre-market trading after the company announced a $500 million private offering of convertible senior notes.
  • Almonty Industries Inc. (NASDAQ:ALM) dipped 8.5% to $4.06 in pre-market trading.
  • Synovus Financial Corp. (NYSE:SNV) fell 8.3% to $51.88 in pre-market trading. Pinnacle and Synovus announced an $8.6 billion all-stock merger.
  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) declined 5.2% to $12.20 in pre-market trading. Citigroup analyst Yigal Nochomovitz, on Thursday, initiated coverage on Sarepta Therapeutics with a Sell rating and announced a price target of $7.
  • ABIVAX Société Anonyme (NASDAQ:ABVX) fell 4% to $66.99 in pre-market trading. Abivax announced full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5 million (€637.5 million).
  • Semler Scientific, Inc. (NASDAQ:SMLR) fell 3.6% to $37.50 in pre-market trading.

Now Read This:

Photo via Shutterstock

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.